4-Hydroxy-3-methoxy-5-nitrobenzaldehyde

Catalog No. :
ACRXNV593
CAS No. :
6635-20-7
Molecular Formula :
C8H7NO5
Molecular Weight :
197.15

IUPAC Name:4-hydroxy-3-methoxy-5-nitrobenzaldehyde

4-Hydroxy-3-methoxy-5-nitrobenzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$138.00Login to see priceIn stockInquiry
1000g97%$236.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Hydroxy-3-methoxy-5-nitrobenzaldehyde
IUPAC Name4-hydroxy-3-methoxy-5-nitrobenzaldehyde
MDL No.MFCD00007118
Molecular FormulaC8H7NO5
Molecular Weight197.15
SMILESC1=C(C=O)C=C(C(=C1[N+](=O)[O-])O)OC
InChI KeyZEHYRTJBFMZHCY-UHFFFAOYSA-N
Synonym5-nitrovanilline | SCHEMBL344482 | 3-methoxy-4-hydroxy-5-nitrobenzaldehyde | 4-Hydroxy-3-methoxy-5-nitrobenzaldehyde # | InChI=1/C8H7NO5/c1-14-7-3-5(4-10)2-6(8(7)11)9(12)13/h2-4,11H,1H | NSC35352 | NSC-35352 | 5-nitro vanillin | 5-Nitrovanillin | NSC 3535
CAS No.6635-20-7
PubChem CID81134

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRXNV593 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTMB767 route compound structure diagram
    ACHTMB76713126-12-0
  4. Then
  5. ACRXNV593 route product structure diagram
    ACRXNV5936635-20-7 In Stock
Inquiry

2. ACRXNV593 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. ACHTMB767 route compound structure diagram
    ACHTMB76713126-12-0
  6. Then
  7. ACRXNV593 route product structure diagram
    ACRXNV5936635-20-7 In Stock
Inquiry

Comments (0)